Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?
In Brief; “Sense of Urgency” In Research Is Theme of New AACR President Daniel Von Hoff
Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time
CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years
Komen, ACS Support Payment Off-Protocol; Dilemma for Advocates
NCI Programs: Pediatric Brain Tumor Grants Awarded
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- How will FDA regulate psychedelics?
- The future of oncology: Early-career scientists need mentorship and a new academic model
- The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long” - OMB proposal to sideline peer review sparks widespread opposition
Nearly 500,000 public comments flood in—here are some highlights - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care









